16
POPSNanoparticle 'smart bomb' targets drug delivery to cancer cells The researchers say that the virus is appealing in both its ability to survive outside of a plant host and its built-in "cargo space" of 17 nanometers, which can be used to carry chemotherapy drugs directly to tumor cells. "Another factor that makes the virus unique is the toughness of its shell," Lommel says. "When the virus is in a closed state, nothing will leak out of the interior, and when it does open, it opens slowly, which means that the virus has time to enter the cell nucleus before deploying its cargo, which increases the drug's efficacy."
20
POPSBulls Cloned From Decade-Old Frozen Testicles This type of cloning is harder to pull off, and scientists haven't yet figured out how to replace DNA damaged by Siberian deep-freezing. But researchers are also consistently amazed at the boundaries to which artificial reproduction can be pushed. "It's still very much a long shot, but it's not out and out impossible," said George Seidel, a Colorado State University animal reproduction expert, when I talked to him in November about mammoth cloning. "It's remarkable what one can do with embryos and get away with."
16
POPSThe Promise and Power of RNA RNA interference, or RNAi, discovered only about 10 years ago, is attracting huge interest for its seeming ability to knock out disease-causing genes. There are already at least six RNAi drugs being tested in people, for illnesses including cancer and an eye disease. And while there are still huge challenges to surmount, that number could easily double in the coming year. “I’ve never found a gene that couldn’t be down-regulated by RNAi,” said Tod Woolf, president of RXi Pharmaceuticals, one of the many companies that have sprung up in the last few years to pursue RNA-based medicines. The two scientists credited with discovering the basic mechanism of RNA interference won the Nobel Prize in Physiology or Medicine in 2006, only eight years after publishing their seminal paper. And three scientists credited with discovering the closely related micro-RNA in the 1990s won Lasker Awards for medical research this year.
12
POPSFuture for clean energy lies in 'big bang' of evolution For humans now there is the tantalising possibility of tweaking the photosynthetic reactions of cyanobacteria to produce fuels we want such as hydrogen, alcohols or even hydrocarbons, rather than carbohydrates. Progress at the research level has been rapid, boosting prospects of harnessing photosynthesis not just for energy but also for manufacturing valuable compounds for the chemical and biotechnology industries. Such research is running on two tracks, one aimed at genetically engineering real plants and cyanobacteria to yield the products we want, and the other to mimic their processes in artificial photosynthetic systems built with human-made components. Both approaches hold great promise and will be pursued in parallel, as was discussed at a recent workshop focusing on the photosynthetic reaction centres of cyanobacteria, organised by the European Science Foundation (ESF).
22
POPSDrug tries to offset 10,000 years of evolution Gene therapies, expected some time between 2015 and 2020, promise to correct this genetic problem caused by nature, but many obese people do not want to wait. They are hoping that Nastech’s new nasal spray can provide a solution now. Within 20 to 35 minutes after taking a whiff, this new drug moves quickly through the nasal lining and into the bloodstream, sending a message to the brain that our tummy is full. So far the drug has had no negative side effects. PYY is undergoing clinical trials now, and is expected to be in drug stores by 2009 or 2010. Obesity is the 2nd leading cause of preventable death in America, so this drug offers a great chance for more people to improve their health and get ready to enjoy our “magical future”.
13
POPSWhen Unusually Rapid Improvement Becomes Usual Given the existing pressure on such social programs as Social Security and Medicare, I believe one implication of this “unusually rapid improvement” is that these systems will need to be radically overhauled in order to survive this new demographic reality.
11
POPSBacterial Chemical Sensors on the Horizon? Bacteria is responsible for the vast majority of all fundamental life processes on this planet. Harnessing bacteria to the service of humanity will be a technological revolution allowing anything from supersensitive sensors to weather control.
6
POPSGenetically modified human embryo stirs criticism It is definitely unacceptable to try it when it is unsafe. It is definitely worth trying when it will be safe. It will be safe eventually, our job meanwhile is to create an adequate ethical framework that will allow the harnessing of this future technology to the benefit of all humans and other beings.
10
POPSNano RNA Delivery Novel delivery agents could mean a more targeted way to turn off disease genes. The MIT researchers, however, developed a way to make more than a thousand different delivery agents in parallel using a simple, one-step chemical process. And that allowed the team to quickly discover effective delivery molecules, including several that surprised the researchers. "We wouldn't have necessarily sat down and said, this is a structure that's going to work," says Daniel Anderson, a research associate at the David H. Koch Institute for Integrative Cancer Research at MIT. "It was only by making and testing over a thousand that we were able to get to that place."
9
POPSLife 2.0. A fascinating article of what seems to be near future breakthrough that will radically change the course of human existence. The line between science and science fiction seems to become ever thinner